Amicus Therapeutics Seeks FDA Approval for Drug to Treat Fabry Disease
Amicus Therapeutics is a biopharmaceutical company based in New Jersey that puts an extraordinary amount of focus on developing advanced treatments for rare diseases and disorders. Amicus Therapeutics...
View ArticleEric Lefkofsky’s Tempus Launches Tempus xT and Takes a Step Toward Precision...
Tempus, a tech company and also one of Chicago’s top ten tech startups, has announced its launch of a new comprehensive genomic sequencing panel. Also known as Tempus xT, the panel has the capacity to...
View Article
More Pages to Explore .....